Cargando…
Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer
BACKGROUND: Nearly half of muscle-invasive bladder cancer patients succumb to their disease following cystectomy. Selecting candidates for adjuvant therapy is currently based on clinical parameters with limited predictive power. This study aimed to develop and validate genomic-based signatures that...
Autores principales: | Mitra, Anirban P., Lam, Lucia L., Ghadessi, Mercedeh, Erho, Nicholas, Vergara, Ismael A., Alshalalfa, Mohammed, Buerki, Christine, Haddad, Zaid, Sierocinski, Thomas, Triche, Timothy J., Skinner, Eila C., Davicioni, Elai, Daneshmand, Siamak, Black, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241889/ https://www.ncbi.nlm.nih.gov/pubmed/25344601 http://dx.doi.org/10.1093/jnci/dju290 |
Ejemplares similares
-
Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
por: Vergara, Ismael A., et al.
Publicado: (2012) -
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
por: Erho, Nicholas, et al.
Publicado: (2013) -
Transcriptome-Wide Detection of Differentially Expressed Coding and Non-Coding Transcripts and Their Clinical Significance in Prostate Cancer
por: Erho, Nicholas, et al.
Publicado: (2012) -
Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group
por: Badani, Ketan, et al.
Publicado: (2013) -
Evolving transcriptomic fingerprint based on genome‐wide data as prognostic tools in prostate cancer
por: Alshalalfa, Mohammed, et al.
Publicado: (2015)